Successful treatment of spleen tuberculosis in a patient with human immunodeficiency virus infection

R. Maserati, E. Seminari, L. Scudeller, L. Rizzi, M. Benedetti, L. Minoli

Research output: Contribution to journalArticlepeer-review

Abstract

Tuberculosis in human immunodeficiency virus (HIV) infected patients may act as a cofactor that accelerates the clinical course of HIV infection, and, indeed, HIV-infected patients with tuberculosis have a reduced survival rate compared to those without tuberculosis. Diagnosis of tuberculosis in HIV-positive patients can be difficult because of nonspecific symptoms and the time required for the identification of mycobacteria by means of culture techniques. Recently, antiretroviral combination therapies have improved the outcome of several acquired immune deficiency syndrome (AIDS)-associated conditions. Unfortunately, the use of antiretroviral therapy for patients coinfected with HIV and Mycobacterium tuberculosis is still to be fully evaluated. The complexity of side-effects due to antituberculosis medication and drug interaction represent important issues and combining an effective anti-HIV treatment with antituberculosis therapy is still a clinical challenge. We discuss here a case of spleen tuberculosis in a human immunodeficiency virus-positive patient who had a successful response after a diagnostic splenectomy and medical treatment that included classical antituberculosis treatment associated with antiretroviral therapy without protease inhibitors.

Original languageEnglish
Pages (from-to)130-132
Number of pages3
JournalMonaldi Archives for Chest Disease - Cardiac Series
Volume54
Issue number2
Publication statusPublished - 1999

Keywords

  • Antiretroviral therapy
  • Human immunodeficiency virus infection
  • Spleen tuberculosis

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Successful treatment of spleen tuberculosis in a patient with human immunodeficiency virus infection'. Together they form a unique fingerprint.

Cite this